CAPITAL STOCK (Details)													1 Months Ended	12 Months Ended
	Dec. 10, 2020 USD ($)	Oct. 07, 2020 USD ($) $ / shares shares	Oct. 01, 2020 USD ($) shares	Dec. 21, 2019 USD ($) $ / shares shares	Nov. 15, 2019 $ / shares shares	Oct. 31, 2019 $ / shares	Aug. 22, 2019 USD ($) $ / shares shares	Aug. 07, 2019 $ / shares shares	Jan. 25, 2019 USD ($) shares	Dec. 26, 2018 $ / shares shares	Dec. 21, 2018 USD ($) $ / shares shares	Nov. 15, 2018	Dec. 31, 2018 USD ($) $ / shares shares	Sep. 30, 2020 USD ($) $ / shares shares	Sep. 30, 2019 USD ($) $ / shares shares	Sep. 16, 2020 shares	Sep. 15, 2020 shares	Nov. 01, 2019 $ / shares
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Reverse stock split						0.025
Common stock, par value | $ / shares						$ 0.001								$ 0.001	$ 0.001			$ 0.001
Common stock, shares authorized														200,000,000	500,000,000	200,000,000	500,000,000
Common stock issued in private placement, net of offering costs (in shares)								100,617
Exercise price of warrants (in dollars per share) | $ / shares				$ 17.60	$ 5.60			$ 20.00
Number of warrants outstanding								143,252						1,038,919	263,592
Incremental change in fair value of warrants | $				$ 281,042
Number of warrants exercised														1,649,786
Net proceeds from exercise of warrants | $														$ 8,055,797	$ 987,501
Accredited investors
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Common stock issued in private placement, net of offering costs (in shares)							38,704
Common stock, issue price | $ / shares							$ 10.80
Total Gross Proceeds | $							$ 418,000
Accredited investors, minimum stockholding percentage							5.00%
Subsequent event
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Net proceeds from exercise of warrants | $	$ 1,100,000
Offering
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Common stock issued in private placement, net of offering costs (in shares)					2,285,000
Number of common stock called by warrants					2,285,000
Number of common shares that each warrant has right to purchase					1
Exercise price of warrants (in dollars per share) | $ / shares					$ 5.25								$ 5.60	$ 12.00
Public offering price for each share together with warrant | $ / shares					$ 5.25
Additional number of common stock called by warrants					342,750
Warrants exercisable expiration period												45 days
Number of warrants outstanding													8,375
Incremental change in fair value of warrants | $													$ 2,842	$ 78,785
Number of warrants exercised														1,649,786
Net proceeds from exercise of warrants | $														$ 8,100,000
Offering | Subsequent event
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Exercise price of warrants (in dollars per share) | $ / shares		$ 5.25
Number of warrants outstanding		661,000
Number of warrants exercised		318,000	518,551
Net proceeds from exercise of warrants | $		$ 1,669,500	$ 2,600,000
Underwriting Agreement [Member] | Maxim Group Llc [Member]
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Common stock issued in private placement, net of offering costs (in shares)											137,500
Number of common stock called by warrants											137,500
Exercise price of warrants (in dollars per share) | $ / shares											$ 20.00
Public offering price for each share together with warrant | $ / shares											$ 20.00
Additional number of common stock called by warrants											20,625
Gross proceeds of offering before underwriter discounts, commissions and other offering expenses | $											$ 2,750,000
Net proceeds from offering after deducting underwriting fees and other expense | $											$ 2,262,000
Minimum exercise price | $ / shares											$ 5.60
Determinant for number of shares issued on exercise of warrants											0.70
Number of warrants outstanding				68,375
Number of warrants purchased										20,000
Term of warrants											5 years
Purchase price per warrant (in dollars per warrant) | $ / shares										$ 0.0000004
Underwriting Agreement [Member] | Maxim Group Llc [Member] | Over-Allotment Option [Member]
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Number of aggregate common stock issued including exercise of over-allotment option									150,000
Gross amount of common stock and warrants issued including exercise of over-allotment option | $									$ 3,000,000
Net amount of common stock and warrants issued including exercise of over-allotment option | $									$ 2,500,000
Number of common shares issued under underwriters partial exercise of over-allotment option									12,500
Amount of common shares issued under underwriters partial exercise of over-allotment option | $									$ 250,000
Number of warrants issued including exercise of over-allotment option									157,500
Net proceeds from over allotment after deducting underwriting fees and other expense | $									$ 201,000